Biopreservation market seen growing to $12.43 billion by 2030

The global biopreservation market is projected to rise from $6.69 billion in 2025 to $7.58 billion in 2026, with North America holding the largest share. The Business Research Company says demand for personalized medicine, regenerative medicine samples and biorepository investment will keep driving growth through 2030.

Why it matters: - Biopreservation underpins biobanking, diagnostics and research that depend on keeping biological samples usable over time. - Stronger sample storage and preservation capabilities can improve clinical research, personalized medicine and regenerative medicine pipelines. - The market's expected growth signals rising spending on infrastructure, equipment and long-term sample management.

What happened: - The Business Research Company published its Biopreservation Market Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report values the biopreservation market at $6.69 billion in 2025. - The market is projected to reach $7.58 billion in 2026, a 13.3% CAGR. - The market is forecast to grow to $12.43 billion by 2030, at a 13.2% CAGR. - North America held the largest share of the biopreservation market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - Download a free sample of the report. - View the full market report.

The details: - The earlier growth was driven by more biobanking operations, more clinical research projects and greater use of biospecimens in diagnostics. - Better access to preservation equipment and standardized storage procedures also supported market growth. - Future growth is expected to come from higher demand for regenerative medicine samples and precision medicine studies. - Rising investment in biorepository infrastructure and a stronger focus on sample quality are also expected to support expansion. - The report points to continued growth in clinical trial activity worldwide. - Expected market trends include broader use of advanced cryopreservation methods. - Other trends include greater demand for long-term biospecimen storage, wider use of specialized preservation media, more centralized biorepository centers and stronger emphasis on sample integrity and traceability. - In medical and research use, biopreservation includes methods for preserving biospecimens such as urine, blood, tissues, cells and DNA. - Those samples are stored in biorepositories for future research or diagnostic use.

Between the lines: - Personalized medicine is a major demand driver because it depends on stored human tissues and cells that remain viable for later testing and treatment development. - The report cites data from the Personalized Medicine Coalition showing the FDA approved 16 new personalized therapies for rare diseases in 2023, up from six in 2022. - That jump suggests continued pressure on biobanks and preservation systems as more therapies require specialized biological samples. - The report's focus on market attractiveness scoring, TAM analysis, company scoring matrices and forecast dashboards signals a sales-oriented product aimed at investors and industry planners.

What's next: - Biopreservation demand is likely to keep rising as precision medicine, regenerative medicine and clinical trial activity expand. - The report expects more investment in sample integrity systems, preservation media and centralized storage facilities. - North America is expected to remain a major market, while other regions gain ground as awareness and infrastructure improve. - The Business Research Company lists Saumya Sahay as a contact for expert inquiries at marketing@tbrc.info and provides regional phone numbers for the Americas, Asia and Europe.